B J Smits - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B J Smits

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

British Medical Journal (Clinical Research Ed.)|April 14, 1984

Carcinoid tumour secreting dopaB K Sharma, B J Smits, R Robinson, et al.

Immunological Reviews|February 1, 1997

Killer cell receptors: keeping pace with MHC class I evolutionN M Valiante, K Lienert, H G Shilling, et al.

Alimentary Pharmacology & Therapeutics|February 1, 1994

Lack of evidence of neurotoxicity following 8 weeks of treatment with tripotassium dicitrato bismuthateC U Nwokolo, J D Fitzpatrick, R Paul, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancerP A Burch, J K Breen, J C Buckner, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

British Medical Journal (Clinical Research Ed.)|April 14, 1984

Carcinoid tumour secreting dopaB K Sharma, B J Smits, R Robinson, et al.

Immunological Reviews|February 1, 1997

Killer cell receptors: keeping pace with MHC class I evolutionN M Valiante, K Lienert, H G Shilling, et al.

Alimentary Pharmacology & Therapeutics|February 1, 1994

Lack of evidence of neurotoxicity following 8 weeks of treatment with tripotassium dicitrato bismuthateC U Nwokolo, J D Fitzpatrick, R Paul, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancerP A Burch, J K Breen, J C Buckner, et al.

Pageof 2